Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-guided antiplatelet monotherapy after elective PCI in chronic coronary syndrome
NL-OMON58623Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel, ticagrelor, clopidogrel and aspirin in coronary arteriosclerosis and Chronic Coronary Syndrome (CCS) (2 arms), sponsored by St. Antonius Ziekenhuis. Started Jan 2024; status: completed.
02
Drugs
prasugrelticagrelorclopidogrelaspirin
03
Conditions
coronary arteriosclerosisChronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NL-OMON58623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58623.